GENERICO.ruWorldUS Medical Regulator Approves Pfizer's COVID-19 Pill

US Medical Regulator Approves Pfizer's COVID-19 Pill


WASHINGTON, Dec 22 Pfizer's coronavirus, dubbed Paxlovid, will be available only by prescription and indicated for use as soon as COVID-19 is diagnosed or within five days of symptom onset. “Today the Food and Drug Administration (FDA) The United States has issued an Emergency Use Authorization for Paxlovid to Pfizer for the treatment of mild to moderate coronavirus disease in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with direct SARS test positive CoV-2, who are at high risk of progression of COVID-19 to severe form, including hospitalization or death, “- said in a press release The regulator named impairment of taste sensations, diarrhea, high blood pressure and muscle pain as possible side effects. Pre-omicron studies have shown that Paxlovid reduces the risk of hospitalization or death from coronavirus by 89%. Two doses Pfizer vaccines are ineffective for children 2 years and older

LEAVE A REPLY

Please enter your comment!
Please enter your name here

LATEST POSTS in this category